Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts

Prostate

Volumn 72, Issue 4, 2012, Pages 437-449

  Yu, Shengqiang ^a   Yeh, Chiuan Ren ^a   Niu, Yuanjie ^a,b   Chang, Hong Chiang ^a,c   Tsai, Yu Chieh ^a,b   Moses, Harold L ^d   Shyr, Chih Rong ^a,e   Chang, Chawnshang ^a,e   Yeh, Shuyuan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Medical University   (China)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d VANDERBILT UNIVERSITY   (United States)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

androgen receptor; Cre loxP; epithelium; fibroblast specific protein; prostate

Indexed keywords

ANDROGEN RECEPTOR; CALVASCULIN; COLLAGEN; GROWTH FACTOR; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; FIBROBLAST; GENE DELETION; GROWTH RETARDATION; MALE; MOUSE; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE; PROSTATE DEVELOPMENT; PROTEIN EXPRESSION; STROMA CELL; TESTOSTERONE BLOOD LEVEL;

ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; EPITHELIAL CELLS; FIBROBLASTS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; PROSTATE; RECEPTORS, ANDROGEN; STROMAL CELLS; TESTOSTERONE;

EID: 84856026139     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21445     Document Type: Article

References (50)

1. Jackson RS 2nd, Franco OE, Bhowmick NA,. Gene targeting to the stroma of the prostate and bone. Differentiation 2008; 76 (6): 606-623. (Pubitemid 352032739)
2. Prins GS, Putz O,. Molecular signaling pathways that regulate prostate gland development. Differentiation 2008; 76 (6): 641-659. (Pubitemid 352032742)
3. Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, Wang C, Mizokami A,. Androgen receptor: An overview. Crit Rev Eukaryot Gene Expr 1995; 5 (2): 97-125.
4. Galani A, Kitsiou-Tzeli S, Sofokleous C, Kanavakis E, Kalpini-Mavrou A,. Androgen insensitivity syndrome: Clinical features and molecular defects. Hormones (Athens) 2008; 7 (3): 217-229.
5. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C,. Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 2002; 99 (21): 13498-13503. (Pubitemid 35215410)
6. Thomson AA,. Mesenchymal mechanisms in prostate organogenesis. Differentiation 2008; 76 (6): 587-598. (Pubitemid 352032749)
7. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA,. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 1992; 13 (6): 465-475.
8. Cooke PS, Young P, Cunha GR,. Androgen receptor expression in developing male reproductive organs. Endocrinology 1991; 128 (6): 2867-2873.
9. Cunha GR, Lung B,. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J Exp Zool 1978; 205 (2): 181-193.
10. Cunha GR, Chung LW,. Stromal-epithelial interactions-I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice. J Steroid Biochem 1981; 14 (12): 1317-1324. (Pubitemid 12136929)
11. Takeda H, Lasnitzki I, Mizuno T,. Change of mosaic pattern by androgens during prostatic bud formation in XTfm/X+ heterozygous female mice. J Endocrinol 1987; 114 (1): 131-137. (Pubitemid 17113160)
12. Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C,. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci USA 2007; 104 (31): 12679-12684. (Pubitemid 47255214)
13. Yu S, Zhang C, Lin CC, Niu Y, Lai KP, Chang HC, Yeh SD, Chang C, Yeh S,. Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells. Prostate 2011; 71 (5): 517-524.
14. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL,. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303 (5659): 848-851. (Pubitemid 38174665)
15. Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA,. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res 2008; 68 (12): 4709-4718.
16. Zhang C, Yeh S, Chen YT, Wu CC, Chuang KH, Lin HY, Wang RS, Chang YJ, Mendis-Handagama C, Hu L, Lardy H, Chang C,. Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells. Proc Natl Acad Sci USA 2006; 103 (47): 17718-17723. (Pubitemid 44852226)
17. Yeh S, Hu YC, Wang PH, Xie C, Xu Q, Tsai MY, Dong Z, Wang RS, Lee TH, Chang C,. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. J Exp Med 2003; 198 (12): 1899-1908. (Pubitemid 38032122)
18. Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C,. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 2008; 105 (34): 12182-12187.
19. Mainwaring PN, Ellis PA, Detre S, Smith IE, Dowsett M,. Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer. J Clin Pathol 1998; 51 (1): 34-37. (Pubitemid 28122583)
20. Ilio KY, Nemeth JA, Lang S, Lee C,. The primary culture of rat prostate basal cells. J Androl 1998; 19 (6): 718-724. (Pubitemid 29011250)
21. Niu Y, Altuwaijri S, Yeh S, Lai KP, Yu S, Chuang KH, Huang SP, Lardy H, Chang C,. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci USA 2008; 105 (34): 12188-12193.
22. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ,. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006; 4 (1): 38.
23. Thornton M, Frederickson R, Mata L, Mawhinney M,. Collagen and the proliferation and differentiation of rat ventral prostate epithelial cells. Biol Reprod 1985; 33 (1): 213-227.
24. Singh I,. A modification of the Masson-trichrome stain. Indian J Pathol Bacteriol 1969; 12 (4): 172-173.
25. Chang JY, Kessler HP,. Masson trichrome stain helps differentiate myofibroma from smooth muscle lesions in the head and neck region. J Formos Med Assoc 2008; 107 (10): 767-773.
26. Rodella LF, Rezzani R, Buffoli B, Bonomini F, Tengattini S, Laffranchi L, Paganelli C, Sapelli PL, Bianchi R,. Role of mast cells in wound healing process after glass-fiber composite implant in rats. J Cell Mol Med 2006; 10 (4): 946-954.
27. Cross NA, Reid SV, Harvey AJ, Jokonya N, Eaton CL,. Opposing actions of TGFbeta1 and FGF2 on growth, differentiation and extracellular matrix accumulation in prostatic stromal cells. Growth Factors 2006; 24 (4): 233-241. (Pubitemid 46964983)
28. Giri D, Ropiquet F, Ittmann M,. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol 1999; 180 (1): 53-60. (Pubitemid 29249712)
29. Sordello S, Bertrand N, Plouet J,. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochem Biophys Res Commun 1998; 251 (1): 287-290. (Pubitemid 28498104)
30. Matsumoto K, Suzuki K, Koike H, Hasumi M, Matsui H, Okugi H, Shibata Y, Ito K, Yamanaka H,. Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia. Anticancer Res 2003; 23 (5A): 3767-3773. (Pubitemid 37474323)
31. Heinlein CA, Chang C,. Androgen receptor in prostate cancer. Endocr Rev 2004; 25 (2): 276-308. (Pubitemid 38501396)
32. Cunha GR, Cooke PS, Kurita T,. Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol 2004; 67 (5): 417-434. (Pubitemid 40424552)
33. Prins GS, Birch L,. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 1995; 136 (3): 1303-1314.
34. Berry PA, Maitland NJ, Collins AT,. Androgen receptor signalling in prostate: Effects of stromal factors on normal and cancer stem cells. Mol Cell Endocrinol 2008; 288 (1-2): 30-37.
35. Katoh M,. Cancer genomics and genetics of FGFR2 (Review). Int J Oncol 2008; 33 (2): 233-237.
36. Donjacour AA, Thomson AA, Cunha GR,. FGF-10 plays an essential role in the growth of the fetal prostate. Dev Biol 2003; 261 (1): 39-54. (Pubitemid 36993819)
37. Guo L, Degenstein L, Fuchs E,. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 1996; 10 (2): 165-175. (Pubitemid 26044604)
38. Cunha GR, Ricke W, Thomson A, Marker PC, Risbridger G, Hayward SW, Wang YZ, Donjacour AA, Kurita T,. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 2004; 92 (4): 221-236. (Pubitemid 40136583)
39. Le Roith D,. The insulin-like growth factor system. Exp Diabesity Res 2003; 4 (4): 205-212. (Pubitemid 38035562)
40. Ruan W, Powell-Braxton L, Kopchick JJ, Kleinberg DL,. Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 1999; 140 (5): 1984-1989. (Pubitemid 30639064)
41. Wu Y, Zhao W, Zhao J, Pan J, Wu Q, Zhang Y, Bauman WA, Cardozo CP,. Identification of androgen response elements in the insulin-like growth factor I upstream promoter. Endocrinology 2007; 148 (6): 2984-2993. (Pubitemid 46984806)
42. Kojima S, Inahara M, Suzuki H, Ichikawa T, Furuya Y,. Implications of insulin-like growth factor-I for prostate cancer therapies. Int J Urol 2009; 16 (2): 161-167.
43. Li Y, Koeneman KS,. Insulin-like growth factor-I dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Tisheeka R. Graham, Haiyen E. Zhau, Valerie A. Odero-Marah, Adeboye O. Osunkoya, K. Sean Kimbro, Mourad Tighiouart, Tongrui Liu, Jonathan W. Simons, Ruth M. O'Regan, Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA. Urol Oncol 2009; 27 (1): 112.
44. Srinivasan N, Aruldhas MM, Govindarajulu P,. Sex steroid-induced changes in collagen of the prostate and seminal vesicle of rats. J Androl 1986; 7 (1): 55-558.
45. Kiefer JA, Farach-Carson MC,. Type I collagen-mediated proliferation of PC3 prostate carcinoma cell line: Implications for enhanced growth in the bone microenvironment. Matrix Biol 2001; 20 (7): 429-437. (Pubitemid 33016380)
46. Kiefer J, Alexander A, Farach-Carson MC,. Type I collagen-mediated changes in gene expression and function of prostate cancer cells. Cancer Treat Res 2004; 118: 101-124.
47. Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW,. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 2007; 67 (9): 4244-4253. (Pubitemid 46815071)
48. Ayala GE, Dai H, Tahir SA, Li R, Timme T, Ittmann M, Frolov A, Wheeler TM, Rowley D, Thompson TC,. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res 2006; 66 (10): 5159-5164. (Pubitemid 43844938)
49. Li Y, Li CX, Ye H, Chen F, Melamed J, Peng Y, Liu J, Wang Z, Tsou HC, Wei J, Walden P, Garabedian MJ, Lee P,. Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion. J Cell Mol Med 2008; 12 (6B): 2790-2798.
50. Gao J, Isaacs JT,., Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells. Cancer Res 1998; 58 (15): 3299-3306. (Pubitemid 28371069)